Nadir görülen bir lezyon: Erkek meme kanseri: Olgu sunumu

Erkek meme kanseri nadir görülen malignitelerdendir. Erkeklerde görülen meme kanseri tüm meme kanseri olgularının yaklaşık %1 ini oluşturmaktadır. Belirtilerin ve tanının gecikmesinin nedeni genelde hastalığın nadiren akla getirilmesidir. Biz bu yazımızda meme kanseri tanısı ile tedavi ettiğimiz 57 yaşındaki bir erkek hastamızı sunmayı amaçladık.

Abstract

Male breast malignancies are rare. Cancer of the male breast accounts for about 1% of all breast cancers. Poor level of awareness often results in late presentation and delayed diagnosis. We aimed to present a case report of a 57-year-old man who has breast cancer

Anahtar kelimeler

Orta yaşlı Lenfatik hastalıklar Erkek Mammografi Radyoterapi Kemoterapi adjuvan Meme neoplazmları erkek Biyopsi ince-iğne Middle Aged Lymphatic Diseases Male Mammography Radiotherapy Chemotherapy Adjuvant Breast Neoplasms Biopsy Fine-Needle

🔖

Bu Makaleye Atıf Yap

AKÇA, T., ALTUN, U., APAYDIN, D., POLAT, A., AYDIN, S. (2006). Nadir görülen bir lezyon: Erkek meme kanseri: Olgu sunumu. Meme Sağlığı Dergisi, Cilt: 2 - Sayı: 1, 37–39. https://ajindex.com/articles/278210

📄 Tam Metin PDF Okuyucu

Yeni Sekmede Aç ↗

↗Yeni Sekme

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: a population-based study. Cancer 2004, 101: 51-57. (PMID: 15221988
Donegan WL, Redlich PN, Lang PJ, Gall MT. Carcinoma of the breast in males: a multiinstitutional survey. Cancer 1998; 83: 498-509. (PMID: 9690543
Frangou EM, Lawson J, Kanthan R. Angiogenesis in male breast cancer. World J Surg Oncol 2005, 3:16 (e-pub). (PMID: 15743520
Hodgson NC, Button JH, Franceschi D, Moﬀat FL, Livingstone AS. Male breast cancer: Is the incidence increasing? Ann Surg Oncol 2004; 11: 751-755. (PMID: 15289238
Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999; 126: 775-780. (PMID: 10520928
Joshi MG, Lee AK, Loda M, Camus MG, Pedersen C, Heatley GJ, Hughes KS. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome. Cancer 1996; 77: 490-498. (PMID: 86309- 56
Krause W. Male breast cancer - an andrological disease: risk factors and diagnosis. Andrologia 2004; 36: 346-354. (PMID: 15541050
Goss PE, Reid C, Pintilie M, Lim R, Miller N. Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955-1996. Cancer 1999; 85: 629-639. (PMID: 10091- 736
Yıldırım E, Berberoğlu U. Male breast cancer: a 22-year experience. Eur J Surg Oncol 1998; 24: 548-552. (PMID: 9870732
Lynge E, Afonso N, Kaerlev L, Olsen J, Sabroe S, Ahrens W, Eriksson M, Guenel P, Merletti F, Stengrevics A, Suarez-Varela M, Costa-Pererra A, Vyberg M. European multi-centre case-control study on risk factors for rare cancers of unknown aetiology. Eur J Cancer 2005; 41: 601-612. (PMID: 15737566
Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J. Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol 1998; 93: 231-233. (PMID: 9468249
Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy. Cancer Res 2003; 63: 342-347. (PMID: 12543786
Jaiyesimi IA, Buzdar AU, Sahin AA, Ross MA. Carcinoma of the male breast. Ann Intern Med 1992; 117: 771-777. (PMID: 1416579